Boston Scientific and J&J face charges due to Trump's trade strategy, while Stryker and Boston Scientific complete major acquisitions in the medtech sector.

The entities involved

• Stryker Corporation →

  American medical technologies company

  • Norges Bank bought a new position in Stryker Corporation shares, while Vanguard lessened its existing holding.Mon 02:09
  • Medtronic is ramping up its Hugo RAS system to compete with Intuitive Surgical, while its neuroscience unit faces competitive pressure from Stryker and Globus Medical.Sun 14:58
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
  • Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04
• Boston Scientific →

  worldwide developer, manufacturer and marketer of medical devices

  • Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.Thu 06:20

Related events

• Protagonist Therapeutics and Takeda Pharmaceutical Company entered a strategic partnership regarding the Rusfertide drug candidate, while Citi initiated coverage with a Buy rating.Jun 8
• Medical device sales are up in the U.S., but major players like J&J are facing market headwinds due to the VBP program in China.Jun 7
• Stryker Corporation and Microbot Medical are two healthcare companies that are currently competing for investment in the market.Aug 31
• Stryker Corporation, Boston Scientific, and Medtronic plc are competing in the medical device market.Aug 15